Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury.
about
Herbal products: benefits, limits, and applications in chronic liver diseaseThe protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2.A semi-physiologically based pharmacokinetic pharmacodynamic model for glycyrrhizin-induced pseudoaldosteronism and prediction of the dose limit causing hypokalemia in a virtual elderly population.Regulation of hepatic ABCC transporters by xenobiotics and in disease states.Potential drug interactions associated with glycyrrhizin and glycyrrhetinic acid.Pre-Hepatectomy Assessment of Bile Transporter Expression by Gadoxetic Acid-Enhanced MRI in a Rat Model of Liver Cirrhosis.Modulators of the human ABCC2: hope from natural sources?Combination treatment with herbal medicines and Western medicines in atopic dermatitis: Benefits and considerations.Involvement of BID translocation in glycyrrhetinic acid and 11-deoxy glycyrrhetinic acid-induced attenuation of gastric cancer growth.Pharmacokinetic study in mice of galphimine-A, an anxiolytic compound from Galphimia glauca.Isolation of a novel glycyrrhizin metabolite as a causal candidate compound for pseudoaldosteronism
P2860
Q21284956-D6913690-837D-4D8D-83C4-F9286A28F8B0Q34558568-8F0F63F2-9936-424F-81E8-345C67813EF7Q35478170-4512896E-BB7D-492E-B8C6-BA2F02BC0DF0Q35690177-CC574655-9761-47A5-8664-9BE67CD88150Q38397138-ED65562A-EC13-4E71-BEBE-26326F6F1231Q38409403-E3406002-E530-40D5-9C07-05E11C4C0450Q38614964-94108EBC-3F1F-4359-AB54-3EBB5C631614Q38792052-0BA84DEA-EE9C-45B2-9504-D0473D7654BCQ39022995-39282B82-4597-4FF3-8776-1F71CDF56FF6Q50126792-C670DAD7-CBCB-4F56-AF4C-FE9FCE7DD79BQ57805805-35904056-1AF8-4ABC-8FCF-9C78C4EFDA5E
P2860
Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Down-regulation of a hepatic t ...... model of chronic liver injury.
@en
Down-regulation of a hepatic t ...... model of chronic liver injury.
@nl
type
label
Down-regulation of a hepatic t ...... model of chronic liver injury.
@en
Down-regulation of a hepatic t ...... model of chronic liver injury.
@nl
prefLabel
Down-regulation of a hepatic t ...... model of chronic liver injury.
@en
Down-regulation of a hepatic t ...... model of chronic liver injury.
@nl
P2093
P356
P1476
Down-regulation of a hepatic t ...... model of chronic liver injury.
@en
P2093
Akito Watanabe
Hajime Mizukami
Makoto Inoue
Naoko Tsuchiya
Nobuhiro Ohtake
Sachiko Imamura
Seiichi Iizuka
Toshiaki Makino
P304
P356
10.1124/DMD.108.021089
P577
2008-03-24T00:00:00Z